Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Clin Lung Cancer. 2020 Nov 24;22(4):e602–e611. doi: 10.1016/j.cllc.2020.11.005

Table 3.

Annual percent change (APC) in five-year relative survival rates for metastatic lung cancer patients in California (1990–2014).

Five-Year Relative Survival (1990–2010)
APC 95% CI p<0.05
Overall 4.05 3.47 4.64 <0.01*
Age at Diagnosis
 20–64 years 4.23 3.52 4.95 <0.01*
 65–74 years 5.04 3.80 6.29 <0.01*
 ≥75 years 5.15 3.91 6.41 <0.01*
Sex
 Male 4.04 3.13 4.95 <0.01*
 Female 4.35 3.67 5.03 <0.01*
Race/ethnicity
 NHW 4.09 3.46 4.73 <0.01*
 NHB 3.58 2.13 5.05 <0.01*
 Hispanic^
  1990–1997 −5.42 −14.26 4.32 0.25
  1997–2010 5.68 2.74 8.70 <0.01*
 API 4.2 2.86 5.56 <0.01*
Histology
 Small-Cell 2.22 0.84 3.62 <0.01*
 Squamous 2.29 1.17 3.42 <0.01*
 Adenocarcinoma 5.66 4.73 6.60 <0.01*
 Large Cell 4.41 2.22 6.65 <0.01*
 NSCLC NOS 4.97 3.76 6.20 <0.01*
 Other 1.92 −0.92 4.83 0.17